We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Meridian Bioscience Inc (VIVO) NPV

Sell:$32.73 Buy:$32.74 Change: $0.16 (0.49%)
Market closed |  Prices as at close on 12 August 2022 | Switch to live prices |
Change: $0.16 (0.49%)
Market closed |  Prices as at close on 12 August 2022 | Switch to live prices |
Change: $0.16 (0.49%)
Market closed |  Prices as at close on 12 August 2022 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic test kits, primarily for certain gastrointestinal and respiratory infectious diseases and elevated blood lead levels. The Company's segments include Diagnostics and Life Science. The Diagnostics segment consists of manufacturing operations for infectious disease products in Cincinnati, Ohio; Quebec City, Canada; and Modi' in, Israel. The segment also includes blood chemistry products in Billerica, Massachusetts and the sale and distribution of diagnostics products domestically and abroad. The Life Science segment consists of manufacturing operations in Memphis, Tennessee; Boca Raton, Florida; London, England; and Luckenwalde, Germany; and the sale and distribution of bulk antigens, antibodies, polymerase chain reaction (PCR)/quantitative PCR (qPCR) reagents, nucleotides, and bioresearch reagents domestically and abroad.

Contact details

3471 River Hills Dr
United States
+1 (513) 2713700

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$1.43 billion
Shares in issue:
43.75 million
Health Care Supplies
United States
US dollar

Key personnel

  • John McIlwraith
    Chairman of the Board
  • John Kenny
    Chief Executive Officer, Director
  • Andrew Kitzmiller
    Executive Vice President, Chief Financial Officer
  • Tony Serafini-Lamanna
    Executive Vice President - Diagnostics
  • Lourdes Weltzien
    Executive Vice President - Life Science
  • Julie Smith
    Chief Accounting Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.